- Home
- DH vs ENGN Comparison
DH vs ENGN Comparison
Compare DH & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DH
- ENGN
- Stock Information
- Founded
- DH 2011
- ENGN 1999
- Country
- DH United States
- ENGN Canada
- Employees
- DH N/A
- ENGN N/A
- Industry
- DH Computer Software: Prepackaged Software
- ENGN
- Sector
- DH Technology
- ENGN
- Exchange
- DH Nasdaq
- ENGN Nasdaq
- Market Cap
- DH 310.5M
- ENGN 297.7M
- IPO Year
- DH 2021
- ENGN N/A
- Fundamental
- Price
- DH $2.81
- ENGN $4.96
- Analyst Decision
- DH Hold
- ENGN Buy
- Analyst Count
- DH 11
- ENGN 9
- Target Price
- DH $5.35
- ENGN $25.22
- AVG Volume (30 Days)
- DH 1.3M
- ENGN 36.4K
- Earning Date
- DH 05-06-2025
- ENGN 03-10-2025
- Dividend Yield
- DH N/A
- ENGN N/A
- EPS Growth
- DH N/A
- ENGN N/A
- EPS
- DH N/A
- ENGN N/A
- Revenue
- DH $252,202,000.00
- ENGN N/A
- Revenue This Year
- DH N/A
- ENGN N/A
- Revenue Next Year
- DH $3.23
- ENGN N/A
- P/E Ratio
- DH N/A
- ENGN N/A
- Revenue Growth
- DH 0.31
- ENGN N/A
- 52 Week Low
- DH $2.55
- ENGN $4.42
- 52 Week High
- DH $8.35
- ENGN $18.40
- Technical
- Relative Strength Index (RSI)
- DH 31.44
- ENGN 35.35
- Support Level
- DH $2.56
- ENGN $4.90
- Resistance Level
- DH $2.90
- ENGN $5.50
- Average True Range (ATR)
- DH 0.19
- ENGN 0.55
- MACD
- DH 0.03
- ENGN 0.01
- Stochastic Oscillator
- DH 53.54
- ENGN 21.80
About DH Definitive Healthcare Corp.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.